Skip to main content
. 2014 Jan 3;14(3):167–173. doi: 10.1007/s40256-013-0058-8

Fig. 1.

Fig. 1

Effects of ARBs on the various endpoints in placebo-controlled studies [13]. Graphic representation of data. ARBs angiotensin receptor blockers, NS not significant